Cassava Sciences price target raised to $131 from $124 at H.C. Wainwright

H.C. Wainwright analyst Vernon Bernardino raised the firm’s price target on Cassava Sciences to $131 from $124 and keeps a Buy rating on the shares. The firm thinks the shares could be range-bound between $20 and $25 per share in the near term, “potentially creating multiple opportunities to add to or create new positions through year-end 2024.” It cites the a significant fall in the number of diluted shares outstanding for the target increase post the Q1 report.